- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 21.31% | 10,281,496 | $2,742,280,613 | 10,281,496 | New | $266.72 | 13F |
| COAG | HEMAB THERAPEUTICS HOLDINGS | 2.23% | 7,808,627 | $286,810,870 | 7,808,627 | New | $36.73 | 13F |
| DBVT | DBV TECHNOLOGIES S.A. | 2.08% | 18,288,220 | $252,560,318 | 18,288,220 | New | 13G | |
| WVE | Wave Life Sciences, Inc. | 1.78% | 34,314,406 | $209,317,877 | 34,314,406 | New | 13D | |
| FRNM | Freenome, Inc. | 1.48% | 15,367,270 | $183,638,877 | 15,367,270 | New | 13D | |
| ABVX | ABIVAX SA-ADR | 1.17% | 1,132,557 | $150,924,546 | 1,132,557 | New | $133.26 | 13F |
| ORKA | ORUKA THERAPEUTICS INC | 1.15% | 1,554,597 | $147,950,996 | 1,554,597 | New | $95.17 | 13F |
| OBX | Obsidian Therapeutics, Inc. | 0.95% | 5,957,103 | $113,125,386 | 5,957,103 | New | 13G | |
| LTGO | Latigo Biotherapeutics, Inc. | 0.85% | 5,295,690 | $98,288,006 | 5,295,690 | New | 13G | |
| NTLA | INTELLIA THERAPEUTICS INC | 0.60% | 4,526,926 | $76,595,588 | 4,526,926 | New | $16.92 | 13F |
| DFTX | DEFINIUM THERAPEUTICS INC | 0.55% | 1,500,000 | $70,560,000 | 1,500,000 | New | $47.04 | 13F |
| SANA | SANA BIOTECHNOLOGY INC | 0.51% | 18,750,000 | $65,437,500 | 18,750,000 | New | $3.49 | 13F |
| SCTX | Scribe Therapeutics Inc. | 0.28% | 1,802,178 | $34,187,317 | 1,802,178 | New | 13G | |
| IKT | Inhibikase Therapeutics, Inc. | 0.27% | 14,653,994 | $32,385,327 | 14,653,994 | New | 13G | |
| PRLD | PRELUDE THERAPEUTICS INC | 0.27% | 6,475,882 | $34,516,451 | 6,475,882 | New | $5.33 | 13F |
| QTTB | Q32 BIO INC | 0.23% | 2,332,457 | $29,715,502 | 2,332,457 | New | $12.74 | 13F |
| EDIT | EDITAS MEDICINE INC | 0.22% | 8,889,000 | $28,800,360 | 8,889,000 | New | $3.24 | 13F |
| AGEN | Agenus Inc. | 0.21% | 4,344,772 | $26,590,005 | 4,344,772 | New | 13G | |
| ALT | ALTIMMUNE INC | 0.15% | 6,500,000 | $19,760,000 | 6,500,000 | New | $3.04 | 13F |
| AURA | AURA BIOSCIENCES INC | 0.14% | 2,500,000 | $17,750,000 | 2,500,000 | New | $7.1 | 13F |
| FTH | FAETH THERAPEUTICS INC | 0.14% | 722,020 | $18,050,500 | 722,020 | New | $25 | 13F |
| SPTX | SEAPORT THERAPEUTICS INC | 0.12% | 700,000 | $15,204,000 | 700,000 | New | $21.72 | 13F |
| INO | Inovio Pharmaceuticals, Inc. | 0.06% | 10,666,523 | $7,253,236 | 10,666,523 | New | 13G | |
| TCGX | TCGX Acquisition Corp. | 0.05% | 500,000 | $5,880,000 | 500,000 | New | 13G | |
| JATT | JATT II ACQUISITION CORP | 0.04% | 500,000 | $5,680,000 | 500,000 | New | $11.36 | 13F |
| JTTT | JATT III Acquisition Corp | 0.04% | 450,000 | $4,995,000 | 450,000 | New | 13G | |
| AMAN | AMANAT ACQUISITION CORP CL A | 0.03% | 375,000 | $3,810,000 | 375,000 | New | $10.16 | 13F |